TPST · Tempest Therapeutics, Inc.
$0.92
+0.01 (+1.58%)
At close · Aug 7
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our need for additional capital to fund our planned programs and operations and to continue to operate as a going concern”View the 10-Q filed May 14, 2026
Market Cap
$13.36M
Shares
14.81M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-08-13 | Versant Venture Capital VI, L.P. | Owner | 387,999 | 2024-08-12 | Jones Trading Institutional Services LLC |
| 2024-08-09 | Versant Venture Capital VI, L.P. | 10% Stockholder | 400,000 | 2024-08-08 | BTIG, LLC |
| 2023-11-02 | Dubensky Thomas W. | Officer, Director | 30,000 | 2023-10-25 | Merrill Lynch |
Showing 1–3 of 3 filings